Hensler Surgical Products v. Tobra Medical: Surgical Implant Patent Dispute Ends in Dismissal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Hensler Surgical Products, LLC v. Tobra Medical, Inc. |
| Case Number | 7:19-cv-00240 |
| Court | U.S. District Court for the Eastern District of North Carolina |
| Duration | Dec 2019 – Apr 2024 4 years 4 months |
| Outcome | Dismissed with Prejudice |
| Patent at Issue | |
| Accused Products | Tobra Medical’s Bone Basket product and similar offerings |
Case Overview
The Parties
⚖️ Plaintiff
A specialized surgical products company and patent holder, asserting rights over proprietary surgical implant technology.
🛡️ Defendant
A medical device company whose Bone Basket product line was identified as the primary accused product, competing in surgical implant solutions.
The Patent at Issue
This dispute centered on a key patent covering surgical bone basket technology, an essential component in orthopedic and spinal surgical procedures. Patents are registered with the U.S. Patent and Trademark Office (USPTO) and protect novel functional and design elements.
- • US10493183B2 — Surgical implant technology for bone baskets
Developing a surgical implant product?
Check if your bone basket design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case was dismissed with prejudice pursuant to a joint stipulation filed by both Hensler Surgical Products and Tobra Medical. No monetary damages were publicly disclosed, and no injunctive relief was ordered by the court. The parties explicitly agreed that each would bear its own attorneys’ fees, expenses, and costs, signaling a negotiated resolution rather than a clear judicial victory for either side.
Key Legal Issues
The absence of any published summary judgment ruling or claim construction order suggests the parties either reached a confidential settlement agreement or determined that continued litigation costs outweighed their respective positions. This type of resolution is common in complex medical device patent litigation, where the technical intricacies of claims and potential for high legal fees drive parties towards settlement. The dismissal with prejudice means Hensler cannot refile the same infringement claims against Tobra for the same products under US10493183B2.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in surgical implant technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in surgical implant patents
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Surgical bone basket designs
Active Patent
US10493183B2 remains enforceable
Design-Around Options
Possible with careful analysis
✅ Key Takeaways
Stipulated dismissals with prejudice under Rule 41(a)(1)(A)(ii) resolve party-specific claims but create no claim construction precedent.
Search related case law →Multi-firm defense teams in medical device cases can effectively neutralize plaintiff leverage over extended timelines.
Explore litigation strategies →Frequently Asked Questions
The case centered on U.S. Patent No. US10493183B2 (Application No. US16/393599), covering surgical bone basket technology.
Both parties jointly stipulated to dismissal under Fed. R. Civ. P. 41(a)(1)(A)(ii), with each bearing its own costs. No public explanation of the underlying agreement was filed; this structure typically reflects a negotiated resolution or litigation cost calculus by both sides.
No. The dismissal carries no finding on patent validity. US10493183B2 remains an enforceable U.S. patent that Hensler may assert against other parties.
Companies developing competing surgical implant platforms should treat US10493183B2 as a live patent requiring design differentiation or licensing consideration. Thorough freedom-to-operate (FTO) analysis is crucial before launching new products in this space.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER Case Lookup — 7:19-cv-00240, U.S. District Court for the Eastern District of North Carolina
- USPTO Patent Center — US10493183B2
- U.S. Patent and Trademark Office — Patent Resources
- Cornell Legal Information Institute — Fed. R. Civ. P. 41
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.